Stocks
Heron Therapeutics (HRTX) Net margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | -140.3% | -253.2% | -252.1% | -124.9% | -87.0% | -35.3% | ||
| Changes by years, y/y, % | +91pp | -113pp | +1pp | +127pp | +38pp | -17.7% | |||
Heron Therapeutics. Net margin, %
Heron Therapeutics. Net margin, changes, pp
Heron Therapeutics (HRTX) Net margin US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| Net margin, % | ? | -132.4% | -79.6% | -31.3% | -9.11% | -25.6% | -35.3% | |
| Changes by years, y/y, % | +96pp | +78pp | +59pp | +101pp | +107pp | |||
| Changes by quarters, q/q, % | -23pp | +53pp | +48pp | +22pp | -17pp | |||
